Hunan Jiudian Pharmaceutical Co., Ltd. (300705.SZ)
CNY 23.61
(-0.38%)
CNY 23.61
(-0.38%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.87 Billion CNY | 24.85% |
| 2022 | 2.29 Billion CNY | 31.77% |
| 2021 | 1.74 Billion CNY | 54.35% |
| 2020 | 1.13 Billion CNY | 5.47% |
| 2019 | 1.07 Billion CNY | 13.66% |
| 2018 | 943.21 Million CNY | 22.62% |
| 2017 | 769.2 Million CNY | 93.74% |
| 2016 | 397.03 Million CNY | 24.73% |
| 2015 | 318.31 Million CNY | 18.52% |
| 2014 | 268.57 Million CNY | 6.51% |
| 2013 | 252.15 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 3.06 Billion CNY | 3.69% |
| 2024 Q3 | 3.24 Billion CNY | 5.65% |
| 2024 Q1 | 2.95 Billion CNY | 3.03% |
| 2023 Q1 | 2.44 Billion CNY | 6.12% |
| 2023 Q2 | 2.47 Billion CNY | 1.34% |
| 2023 Q4 | 2.87 Billion CNY | -4.27% |
| 2023 Q3 | 2.99 Billion CNY | 21.28% |
| 2023 FY | 2.87 Billion CNY | 24.85% |
| 2022 Q1 | 1.76 Billion CNY | 1.39% |
| 2022 Q2 | 1.8 Billion CNY | 2.01% |
| 2022 Q3 | 2.03 Billion CNY | 12.94% |
| 2022 Q4 | 2.29 Billion CNY | 12.8% |
| 2022 FY | 2.29 Billion CNY | 31.77% |
| 2021 Q2 | 1.57 Billion CNY | 29.51% |
| 2021 Q4 | 1.74 Billion CNY | 6.4% |
| 2021 Q3 | 1.64 Billion CNY | 4.31% |
| 2021 FY | 1.74 Billion CNY | 54.35% |
| 2021 Q1 | 1.21 Billion CNY | 7.38% |
| 2020 Q4 | 1.13 Billion CNY | 7.12% |
| 2020 Q3 | 1.05 Billion CNY | -0.85% |
| 2020 Q1 | 1.05 Billion CNY | -1.89% |
| 2020 FY | 1.13 Billion CNY | 5.47% |
| 2020 Q2 | 1.06 Billion CNY | 1.21% |
| 2019 FY | 1.07 Billion CNY | 13.66% |
| 2019 Q3 | 1.04 Billion CNY | 7.6% |
| 2019 Q2 | 969.57 Million CNY | 7.11% |
| 2019 Q1 | 905.21 Million CNY | -4.03% |
| 2019 Q4 | 1.07 Billion CNY | 2.77% |
| 2018 Q2 | 829.82 Million CNY | 4.54% |
| 2018 Q3 | 848.57 Million CNY | 2.26% |
| 2018 Q4 | 943.21 Million CNY | 11.15% |
| 2018 FY | 943.21 Million CNY | 22.62% |
| 2018 Q1 | 793.79 Million CNY | 3.2% |
| 2017 Q4 | 769.2 Million CNY | 3.04% |
| 2017 FY | 769.2 Million CNY | 93.74% |
| 2017 Q1 | - CNY | -100.0% |
| 2017 Q3 | 746.48 Million CNY | 77.82% |
| 2017 Q2 | 419.8 Million CNY | 0.0% |
| 2016 Q1 | 360.52 Million CNY | 13.26% |
| 2016 Q3 | - CNY | -100.0% |
| 2016 Q2 | 372.43 Million CNY | 3.3% |
| 2016 Q4 | 397.03 Million CNY | 0.0% |
| 2016 FY | 397.03 Million CNY | 24.73% |
| 2015 Q2 | 313.11 Million CNY | 0.0% |
| 2015 FY | 318.31 Million CNY | 18.52% |
| 2015 Q4 | 318.31 Million CNY | 0.0% |
| 2015 Q3 | 318.31 Million CNY | 1.66% |
| 2015 Q1 | 313.11 Million CNY | 16.58% |
| 2014 Q1 | - CNY | 0.0% |
| 2014 Q4 | 268.57 Million CNY | -10.4% |
| 2014 Q3 | 299.73 Million CNY | 0.0% |
| 2014 FY | 268.57 Million CNY | 6.51% |
| 2013 FY | 252.15 Million CNY | 0.0% |